99 related articles for article (PubMed ID: 2068159)
1. Antisense suppression of N-myc expression inhibits the transdifferentiation of neuroectoderm tumor cell lines.
Whitesell L; Rosolen A; Neckers LM
Prog Clin Biol Res; 1991; 366():45-54. PubMed ID: 2068159
[No Abstract] [Full Text] [Related]
2. Antisense inhibition of CHP100 C-myc expression results in reduced in vitro growth kinetics and loss of in vivo tumorigenesis.
Rosolen A; Toretsky J; Neckers L
Prog Clin Biol Res; 1994; 385():95-101. PubMed ID: 7972241
[No Abstract] [Full Text] [Related]
3. Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines.
Chen J; Chattopadhyay B; Venkatakrishnan G; Ross AH
Cell Growth Differ; 1990 Feb; 1(2):79-85. PubMed ID: 1964795
[TBL] [Abstract][Full Text] [Related]
4. [Effects of antisense N-myc gene on nerve growth factor-induced differentiation of neuroblastoma cell line].
Chen J; Liu T; Zhe X; Jiang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Jun; 21(3):197-202. PubMed ID: 12569653
[TBL] [Abstract][Full Text] [Related]
5. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
[TBL] [Abstract][Full Text] [Related]
6. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
Spengler BA; Lazarova DL; Ross RA; Biedler JL
Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
[TBL] [Abstract][Full Text] [Related]
7. N-myc amplification and neuronal differentiation in human primitive neuroectodermal tumors of the central nervous system.
Rouah E; Wilson DR; Armstrong DL; Darlington GJ
Cancer Res; 1989 Apr; 49(7):1797-801. PubMed ID: 2924321
[TBL] [Abstract][Full Text] [Related]
8. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-labeled N-myc antisense oligonucleotides.
Watanabe N; Sawai H; Ogihara-Umeda I; Tanada S; Kim EE; Yonekura Y; Sasaki Y
J Nucl Med; 2006 Oct; 47(10):1670-7. PubMed ID: 17015904
[TBL] [Abstract][Full Text] [Related]
9. S-cells from a highly N-myc-amplified neuroblastoma are tumorigenic in nude mice.
Sleight BJ; Soukup S; Ballard ET; Parysek LM
Anticancer Res; 1993; 13(6A):2031-6. PubMed ID: 8297111
[TBL] [Abstract][Full Text] [Related]
10. Expression of N-myc, c-myc, and MDR-1 proteins in newly established neuroblastoma cell lines: a study by immunofluorescence staining and flow cytometry.
Gazitt Y; He YJ; Chang L; Koza S; Fisk D; Graham-Pole J
Cancer Res; 1992 May; 52(10):2957-65. PubMed ID: 1374683
[TBL] [Abstract][Full Text] [Related]
11. Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line.
Rosolen A; Whitesell L; Ikegaki N; Kennett RH; Neckers LM
Cancer Res; 1990 Oct; 50(19):6316-22. PubMed ID: 2205380
[TBL] [Abstract][Full Text] [Related]
12. Abrupt reduction of c-myc expression by antisense RNA inducing terminal differentiation and apoptosis of a human esophageal cancer cell line.
Zhao X; Wang X; Zhou C; Peng R; Yan S; Wu M
Sci China B; 1995 May; 38(5):580-9. PubMed ID: 7626199
[TBL] [Abstract][Full Text] [Related]
13. The effect of changes of N-myc products on the gene expression of heat-shock protein (hsp-70) and nucleolin during differentiation of neuroblastoma cells.
Murakami T; Ohmori H; Tsuda T; Higashi K
Prog Clin Biol Res; 1991; 366():65-70. PubMed ID: 2068180
[No Abstract] [Full Text] [Related]
14. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
15. Integrin expression in human neuroblastoma cells with or without N-myc amplification and in ectopic/orthotopic nude mouse tumors.
Flickinger KS; Judware R; Lechner R; Carter WG; Culp LA
Exp Cell Res; 1994 Jul; 213(1):156-63. PubMed ID: 8020586
[TBL] [Abstract][Full Text] [Related]
16. dbl oncogene expression in childhood tumors and tumor cell lines.
Navarro S; Pellín A; Noguera R; Díaz MP; Tsokos M; Triche TJ; Llombart-Bosch A
Diagn Mol Pathol; 1993 Sep; 2(3):158-62. PubMed ID: 8287229
[TBL] [Abstract][Full Text] [Related]
17. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
Raschella G; Romeo A; Negroni A; Pucci S; Dominici C; Castello MA; Bevilacqua P; Felsani A; Calabretta B
Cancer Res; 1994 Apr; 54(8):2251-5. PubMed ID: 8174135
[TBL] [Abstract][Full Text] [Related]
18. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
Ferrandis E; Da Silva J; Riou G; Bénard I
Cancer Res; 1994 Apr; 54(8):2256-61. PubMed ID: 8174136
[TBL] [Abstract][Full Text] [Related]
19. Importance of phenotypic and molecular characterization for identification of a neuroepithelioma tumor cell line, NUB-20.
Yeger H; Mor O; Pawlin G; Kaplinsky C; Shiloh Y
Cancer Res; 1990 May; 50(9):2794-802. PubMed ID: 2158399
[TBL] [Abstract][Full Text] [Related]
20. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
